"Investors will be looking at this and the certainty investors were hoping to gain post the electricity reforms will dissolve... You'd definitely think twice about investing in onshore wind".
Our findings are in conflict with a previous study, reporting that weight gain post career in elite athletes having experienced weight cycling was higher than those observed in non-dieting athletes [ 34].
Consistent with those reports is the observation that weight gain post diagnosis increases risk for breast cancer recurrence; whereas, weight loss in breast cancer survivors improves the chances of long term survival [ 20, 21].
The Nasdaq surged 7.79percentt, a move exceeded only by the 7.94percentt advance on May 30 and the 7.87 percent gain posted last Friday.
Peak activity of fruiting occurred in the dry season (Chapman et al. 2005), and pre-monsoon fruit ripening occurred in the dry period or close to rainfall to gain post-dispersal success (Rathcke and Lacey 1985), enhance dispersal (Prasad and Sharatchandra 1984; Sundrapandian et al. 2005), and to avoid pathogen infection (Augspurger, 1983).
Semiconductor stocks were also higher, as reflected in the 7.56-point gain posted by the Philadelphia Stock Exchanges Semiconductor Stock Index (SOXX).
Consequently, had we been able to feed the mice enough to promote weight gain post-CLP treatment, the acceleration in atheroma may have been even worse.
In order to develop the evidence base for explaining predictors of unhealthy weight gain post-migration, phenomena such as the 'healthy migrant effect', the ANGELO framework and acculturation theory need to be integrated and synthesized.
Other factors that have been associated with weight gain post-breast cancer, though inconsistently, include younger age, pre-menopausal status and/or having a lower body mass index (BMI) at time of diagnosis [ 38].
For OFA, the picture is more complex: weight is negatively correlated with pretreatment OFA (r = −0.37, P < 1 × 10−6), negatively correlated with gain postdrug (r = −0.38, P = 0.00011), but uncorrelated with gain post-placebo (r = −0.01, P = 0.89).
Similarly, weight is positively correlated with EPS pretreatment (r = 0.42, P < 10−6) and gain postdrug (r = 0.46, P = 3.6 × 10−6), but uncorrelated with gain post-placebo (r = −0.03, P = 0.76).
